Arcellx, Inc.
Status: Publicly traded
Direct answer
Arcellx, Inc. is publicly traded on NASDAQ under the ticker ACLX.
Arcellx, Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering immunotherapeutic solutions for patients battling cancer and other intractable diseases. A cornerstone of their pipeline is CART-ddBCMA, an advanced ddCAR product candidate currently undergoing a Phase 1 clinical trial. This investigational treatment targets individuals suffering from relapsed or refractory multiple myeloma (MM)....
Can you invest in Arcellx, Inc.?
Yes. Arcellx, Inc. trades publicly on NASDAQ as ACLX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Arcellx, Inc.
Detailed equity research is provided by MarketSnap.